Blister Packaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Market Overview

The blister packaging market registered a CAGR of 6.18%, during the period of 2021-2026. Increasing pressure on pharmaceutical companies to manufacture medicines that are distinct in packaging and hard to imitate, beyond the basic need of keeping it effective for the purpose it was produced, for it to be made available for patients, owing to rise in diseases and stringent government regulations against counterfeit drugs, are among the major factors propelling the market. Blister packaging offers an efficient method of anti-counterfeit systems, like banknote authentication systems and others.

• The rising need for the level of product safety from manufacturers, consumers, and regulatory organizations making blister packaging an increasingly practical option. Factors like product integrity and extended shelf life are highly necessary for the pharmaceutical sector, considering that most consumers store their drugs in a temperature variant atmosphere that can be harmful to unprotected medicines.
• The use of innovative technologies in blisters, such as radio frequency identification tags (RFID), deployed with a seal applied outside the packaging, is growing due to the potential to provide individual security throughout supply chains. Contamination of samples in blisters only occurs when the protective barrier is broken, when a single tablet or capsule is dispensed or administered.
• The growing need for compliance with safety regulations, coupled with increased demand for convenient and easy-to-use packaging products, is also expected to drive the market's growth and results in the market vendors partnering with technology companies to introduce those features and widen their product differentiation advantages for bulk purchasers.
• There is also a growing demand for pharmaceutical and personal care products in industrialized regions, like North America, Europe, Asia-Pacific, and others, where considerable consumer expenditure is increasing for both pharmaceutical and personal care products. Products, such as capsules, lozenges, sterile products, and liquid cosmetics like perfumes, place a particularly high demand for blister packaging, protection, appearance, and compliance.
• The outbreak of COVID-19, growth in regulatory norms across the world, population health management, inventions, more informed customers, and an increase in OTC drugs have augmented the growth of packaging.

Scope of the Report

Blister pack is a term for several types of pre-formed plastic packaging used for small consumer goods, foods, and for pharmaceuticals. These packaging solutions are useful for protecting products against external factors, such as humidity and contamination, for extended periods of time. Opaque blisters also protect light-sensitive products against UV rays. Such wide base of application has helped it gain traction in the market.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Pharmaceutical Industry Account for a Major Share

• The pharmaceutical sector poses a different set of demands for the blister packaging solutions regarding insulation from external surroundings, high levels of protection, cost-effectiveness, and ease of handling, in addition to retaining the medicine's effectiveness.
• These packs are uniquely suited to meet the stringent standards and highly valued for protective properties, adaptability, cost-effectiveness, and the pharmaceutical and packaging industry requirements.
• When drugs are packaged in blisters, adherence is improved because consumers can keep track of their medications and dosage. The unit dosage feature of blisters reduces the risk of incorrect dosing.
• The retail-level preparation of prescription drugs is troubling pharmacists or pharmaceutical technicians. The administration of medicines in the open atmosphere of the supermarket and drug store can negatively affect sensitive drugs when they are transferred from container to container. Blister packaging can ensure the process of distribution directly to the customer.
• Protecting product integrity remains the primary goal of pharmaceutical packaging, but as in all areas of the packaging industry, there is continued work on cost reduction in the packaging process.
• According to healthcare informatics, diabetes expenditure was USD 42 billion in 2013 and increased to USD 78 billion in 2018. Moreover, blister-packed medicines can prove to be very helpful in the transportation of medicines, such as those used for diabetes, which may be transported over long distances.

To understand key trends, Download Sample Report